NEW YORK, July 22 (GenomeWeb News) - Abbott and Celera Diagnostics have received CE Mark certification for a real-time PCR test for monitoring hepatitis C viral load in patients, allowing the test to be marked in the European Union, the companies announced today.
The test, called the Abbot RealTime HCV assay, has been developed for use on the Abbott m2000 system, an automated instrument that uses real-time PCR technology provided by Applied Biosystems.
In June, Abbott and Celera announced CE Mark certification for the Abbot RealTime HIV-1 assay, also developed for use on the m2000 system.
Abbott said additional tests are in development for its m2000 system, including tests for detecting hepatitis B, chlamydia, and gonorrhea.